Volume | 345,082 |
|
|||||
News | - | ||||||
Day High | 1.29 | Low High |
|||||
Day Low | 1.205 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Longeveron Inc | LGVN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.29 | 1.205 | 1.29 | 1.235 | 1.28 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,597 | 345,082 | $ 1.24 | $ 428,833 | - | 1.205 - 40.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:40:58 | 5 | $ 1.2691 | USD |
Longeveron Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 25.13M | - | 709k | -22.21M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Longeveron News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LGVN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.45 | 1.58 | 1.205 | 1.33 | 454,305 | -0.20 | -13.79% |
1 Month | 1.98 | 2.0799 | 1.205 | 1.62 | 406,640 | -0.73 | -36.87% |
3 Months | 5.20 | 5.858 | 1.205 | 2.59 | 2,356,885 | -3.95 | -75.96% |
6 Months | 18.90 | 23.90 | 1.205 | 3.67 | 1,296,161 | -17.65 | -93.39% |
1 Year | 33.00 | 40.00 | 1.205 | 6.25 | 744,527 | -31.75 | -96.21% |
3 Years | 60.70 | 450.00 | 1.205 | 139.76 | 1,833,720 | -59.45 | -97.94% |
5 Years | 100.00 | 450.00 | 1.205 | 137.36 | 1,747,897 | -98.75 | -98.75% |
Longeveron Description
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS). |